Comparison of Health Care Utilization and Costs for Patients with Asthma by Severity and Health Insurance in Thailand

Dilokthornsakul, Piyameth; Lee, Todd A.; Dhippayom, Teerapon; Jeanpeerapong, Napawan; Chaiyakunapruk, Nathorn

doi:10.1016/j.vhri.2016.03.001

Cited by 11 publications

(4 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Disease severity is considered a major factor influencing health care resource utilication (HCRU) and related costs. Even though severe asthma is not common, its contribution to total costs is high [ 10 – 13 ].…”

Section: Introductionmentioning

confidence: 99%

Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis

Flórez-Tanus

Parra

Zakzuk

et al. 2018

World Allergy Organization Journal

View full text Add to dashboard Cite

BackgroundAsthma is one of the most common chronic respiratory conditions worldwide. Asthma-related economic burden has been reported in Latin America, but knowledge about its economic impact to the Colombian health care system and the influence of disease severity is lacking. This study estimated direct medical costs and health care resource utilization (HCRU) in patients with asthma according to severity in Colombia.MethodsThis study identified all-age patients who had at least one medical event linked to an asthma diagnosis (CIE-10: J45-J46) between 2004 and 2014. Patients were selected if they had a continuous enrollment and uninterrupted insurance coverage between January 1–2015 and December 31–2015 and were categorized into 4 different severity levels using a modified algorithm based on Leidy criteria. Healthcare utilization and costs were estimated in a 1-year period after the identification period. A Generalized Linear Model (GLM) with gamma distribution and log link was used to analyze costs adjusting for patient demographics.ResultsA total of 20,410 patients were included: 69.5% had mild intermittent, 18.0% mild persistent, 6.9% moderate persistent and 5.5% severe persistent asthma; with mean costs (SD) of $67 (134), $482 (1506), $1061 (1983), $2235 (3426) respectively (p < 0.001). The mean total direct cost was estimated at $331 (1278) per patient. Medication and hospitalization had the higher proportion in total costs (46% and 31% respectively). General physician visits was the most used service (57.2%) and short-acting β-2 agonists the most used medication (24%).ConclusionsHealth services utilization and direct costs of asthma were highly related to disease severity. Nationwide health policies aimed at the effective control of asthma are necessary and would play an important role in reducing the associated economic impact.Electronic supplementary materialThe online version of this article (10.1186/s40413-018-0205-4) contains supplementary material, which is available to authorized users.

show abstract

Section: Introductionmentioning

confidence: 99%

Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis

Flórez-Tanus

Parra

Zakzuk

et al. 2018

World Allergy Organization Journal

View full text Add to dashboard Cite

show abstract

“…20 In Thailand, an upper-middle income country in the APR, the average annual cost per patient was USD 599 for the year 2011. 21 These economic estimates are lower for the LMIC in the region, with a retrospective cost analysis in AIRIAP showing a cost of below USD 300 in APR LMIC out of the countries surveyed (Figure 2). Further, this cost analysis represented 13% of per-capita GDP for the entire region, where the individual cost burdens were higher for Vietnam (35%) and Philippines (21%).…”

Section: Burdenmentioning

confidence: 98%

“…For example, the estimated mean cost per patient per year in 2017 for USA and Europe were USD 3100 and USD 1900, respectively 20 . In Thailand, an upper‐middle income country in the APR, the average annual cost per patient was USD 599 for the year 2011 21 . These economic estimates are lower for the LMIC in the region, with a retrospective cost analysis in AIRIAP showing a cost of below USD 300 in APR LMIC out of the countries surveyed (Figure 2).…”

Section: Asthma Prevalence and Disease Burdenmentioning

confidence: 99%

Asthma in developing countries in the Asia‐Pacific Region (APR)

Yasaratne,

Idrose,

Dharmage

2023

Respirology

View full text Add to dashboard Cite

There is growing interest in the epidemiology of asthma in developing countries, especially in the Asia‐Pacific Region (APR). A number of reviews have been published in this field, but a comprehensive synthesis of overall data has not been reported. Here, we summarized the burden, risk factors and challenges of asthma management in developing countries with a specific emphasis on the APR by consolidating evidence from both systematic and narrative reviews published up until February 2023. We found that although asthma prevalence in low and low‐middle‐income countries (LMICs) is known to be generally lower compared to high‐income countries, the burden is substantially greater. Studies conducted in APR LMIC have reported a range of risk factors, including pre‐ and post‐natal factors, environmental considerations, lifestyle measures, individual features and genetics. The low and inequitable distribution of quality preventive and curative health care, a lack of advanced diagnostic measures, non‐availability and non‐affordability of novel therapeutics, cultural beliefs and practices, and diverse disease phenotypes make it challenging to achieve optimal asthma control in the region. Hence, we call for the development of a region‐specific blueprint for action to mitigate this challenging situation, to help reduce the burden of asthma in APR LMIC.

show abstract

“…However, the first healthcare program of universal healthcare coverage to improve financial access was initiated in 2002. Numerous studies have debated and discussed the effectiveness of its design and implementation in reaching the population [85][86][87]. Furthermore, even with the universal healthcare access model deployed in the country, geographic disparities of healthcare facilities still exist and require further discussion and assessment, particularly in remote areas [88,89].…”

Section: Study Areamentioning

confidence: 99%

Disparities in Healthcare Services and Spatial Assessments of Mobile Health Clinics in the Border Regions of Thailand

Sritart

Tuntiwong

Miyazaki

et al. 2021

IJERPH

View full text Add to dashboard Cite

Reducing the disparities in healthcare access is one of the important goals in healthcare services and is significant for national health. However, measuring the complexity of access in truly underserved areas is the critical step in designing and implementing healthcare policy to improve those services and to provide additional support. Even though there are methods and tools for modeling healthcare accessibility, the context of data is challenging to interpret at the local level for targeted program implementation due to its complexity. Therefore, the purpose of this study is to develop a concise and context-specific methodology for assessing disparities for a remote province in Thailand to assist in the development and expansion of the efficient use of additional mobile health clinics. We applied the geographic information system (GIS) methodology with the travel time-based approach to visualize and analyze the concealed information of spatial data in the finer analysis resolution of the study area, which was located in the border region of the country, Ubon Ratchathani, to identify the regional differences in healthcare allocation. Our results highlight the significantly inadequate level of accessibility to healthcare services in the regions. We found that over 253,000 of the population lived more than half an hour away from a hospital. Moreover, the relationships of the vulnerable residents and underserved regions across the province are underlined in the study and substantially discussed in terms of expansion of mobile health delivery to embrace the barrier of travel duration to reach healthcare facilities. Accordingly, this research study addresses regional disparities and provides valuable references for governmental authorities and health planners in healthcare strategy design and intervention to minimize the inequalities in healthcare services.

show abstract

Comparison of Health Care Utilization and Costs for Patients with Asthma by Severity and Health Insurance in Thailand

Abstract: Health care costs of patients with asthma were substantial and were higher in patients with high severe asthma and patients under the CSMBS.

Cited by 11 publications

References 29 publications

Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis

Health care costs and resource utilization for different asthma severity stages in Colombia: a claims data analysis

Asthma in developing countries in the Asia‐Pacific Region (APR)

Disparities in Healthcare Services and Spatial Assessments of Mobile Health Clinics in the Border Regions of Thailand

Contact Info

Product

Resources

About